PMV Pharmaceuticals, Inc. is a precision oncology company, which engages in the discovery and development of small molecule, tumor-agnostic therapies targeting p53. The company was founded by Arnold J. Levine, David Henry Mac, and Thomas E. Shenk in March 2013 and is headquartered in Princeton, NJ.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
54
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. PMV Pharmaceuticals Inc market cap is $66.17M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. PMV Pharmaceuticals Inc 52 week high is $1.91 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. PMV Pharmaceuticals Inc 52 week low is $0.66 as of November 22, 2026.
PMV Pharmaceuticals Inc stock price today is $0.876.
PMV Pharmaceuticals Inc stock price yesterday was $1.31.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. PMV Pharmaceuticals Inc's P/E ratio is -0.57.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. PMV Pharmaceuticals Inc P/B ratio is 1.1587.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. PMV Pharmaceuticals Inc 50-day moving average is $1.37.